Dr. Pierre Kory, M.D., Associate Professor of Medicine at St. Luke’s Aurora Medical Center, delivers passionate testimony during the Senate Homeland Security and Governmental Affairs Committee hearing on “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution.
December 8th, 2020 – Here is Dr. Pierre Kory’s opening statement to the Senate Committee on “Early Outpatient Treatment: An Essential Part of a Covid-19 Solution, Part II”. His testimony can be downloaded at the following link : http://www.hsgac.senate.gov/download/kory12-08-2020
”The 2015 Nobel Prize in Physiology and Medicine was awarded to William C. Campbell and Satoshi Ömura for their discoveries leading to ivermectin . In addition to its extraordinary efficacy against parasitic diseases, ivermectin continues to offer new clinical applications due to its ability to be repurposed to treat new classes of diseases. Beyond its invaluable therapeutic role in onchocerciasis and strongyloidiasis, an increasing body of evidence points to the potential of ivermectin as an antiviral agent.”
”a single dose of ivermectin was able to reduce the replication of an Australian isolate of SARS-CoV-2 in Vero/hSLAM cells by 5000-fold”– from a recently published journal article in ”Ivermectin: an award-winning drug with expected antiviral activity against COVID-19”, Journal of Controlled Release, Science Direct.
There is no need for vaccines when this powerful anti-viral drug can be used to protect us against the virus which has already been proven in a lot of of studies this year.
Part II.” Watch more: Dr. Pierre Kory talks to NewsNOW after emotional Senate hearing on COVID-19
Journal Articles on Treatment of Ivermectin on Covid-19
- Antiviral Research, 178 (2020), p. 10478
The FDA-approved drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro
2. Journal of Controlled Release
Ivermectin: an award-winning drug with expected antiviral activity against COVID-19
3. American Journal of Tropical Medicine and Hygiene. 2020 Jun; 102(6): 1156–1157.
Published online 2020 Apr 16. doi: 10.4269/ajtmh.20-0271
Ivermectin and COVID-19: Keeping Rigor in Times of Urgency
4. Brazilian Journal of Infectious Diseases
Ivermectin: potential candidate for the treatment of Covid 19
5. Journal of Cellular Physiology
Quantitative proteomics reveals a broad‐spectrum antiviral property of ivermectin, benefiting for COVID‐19 treatment
Find hundreds more Journal articles by Doctors in 2020 studies and trials using Ivermectin for Covid patients treatment here